{"id":336536,"date":"2022-01-14T08:49:19","date_gmt":"2022-01-14T07:49:19","guid":{"rendered":"https:\/\/www.pcnen.com\/portal\/?p=336536"},"modified":"2022-01-14T08:49:19","modified_gmt":"2022-01-14T07:49:19","slug":"szo-preporucila-dva-nova-tretmana-protiv-kovida-19","status":"publish","type":"post","link":"https:\/\/www.pcnen.com\/portal\/2022\/01\/14\/szo-preporucila-dva-nova-tretmana-protiv-kovida-19\/","title":{"rendered":"SZO preporu\u010dila dva nova tretmana protiv kovida 19"},"content":{"rendered":"<p>Na listi tretmana koje preporu\u010duje SZO sada je ukupno pet ljekova.<\/p>\n<p>Kako je objavljeno u britanskom medicinskom \u010dasopisu BMJ (British Medical Journal), stru\u010dnjaci SZO preporu\u010duju lije\u010denje kovida 19 sinteti\u010dkim antitijelima, sotrovimabom, i lijekom koji se obi\u010dno koristi protiv reumatoidnog artritisa, baricitinibom, prenosi Beta.<\/p>\n<p>Sotrovimab se preporu\u010duje pacijentima koji su oboljeli od blagog oblika kovida, ali su pod visokim rizikom od hospitalizacije.<\/p>\n<p>Baricitinib se preporu\u010duje za &#8220;pacijente sa te\u0161kim ili kriti\u010dnim kovidom&#8221;, kojima mora da se daje u kombinaciji sa kortikosteroidima.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Svjetska zdravstvena organizacija (SZO) je danas zvani\u010dno preporu\u010dila dva nova tretmana protiv kovida 19 u specifi\u010dnim slu\u010dajevima.<\/p>\n","protected":false},"author":1,"featured_media":285348,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"","_seopress_titles_title":"","_seopress_titles_desc":"","_seopress_robots_index":"","_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","inline_featured_image":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-336536","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vijesti"],"_links":{"self":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/336536","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/comments?post=336536"}],"version-history":[{"count":1,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/336536\/revisions"}],"predecessor-version":[{"id":336537,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/posts\/336536\/revisions\/336537"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media\/285348"}],"wp:attachment":[{"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/media?parent=336536"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/categories?post=336536"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcnen.com\/portal\/wp-json\/wp\/v2\/tags?post=336536"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}